[HTML][HTML] Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver

K Begriche, J Massart, MA Robin… - Journal of …, 2011 - Elsevier
Numerous investigations have shown that mitochondrial dysfunction is a major mechanism
of drug-induced liver injury, which involves the parent drug or a reactive metabolite …

[HTML][HTML] Drug induced steatohepatitis: an uncommon culprit of a common disease

L Rabinowich, O Shibolet - BioMed research international, 2015 - hindawi.com
Nonalcoholic fatty liver disease (NAFLD) is a leading cause of liver disease in developed
countries. Its frequency is increasing in the general population mostly due to the widespread …

[图书][B] Drug-induced liver disease

N Kaplowitz, LD DeLeve - 2007 - taylorfrancis.com
Featuring more than 4100 references, Drug-Induced Liver Disease is an invaluable
reference for gastroenterologists, hepatologists, family physicians, internists, pathologists …

Cytometric analysis for drug-induced steatosis in HepG2 cells

MT Donato, A Martínez-Romero, N Jiménez… - Chemico-biological …, 2009 - Elsevier
Drugs are capable of inducing hepatic lipid accumulation. When fat accumulates, lipids are
primarily stored as triglycerides which results in steatosis and provides substrates for lipid …

Amiodarone hepatotoxicity

M Babatin, SS Lee, PT Pollak - Current vascular pharmacology, 2008 - ingentaconnect.com
Potential hepatotoxicity related to amiodarone therapy is often a concern when deciding
whether to initiate or continue treatment with this medication. While mostly associated with …

Amiodarone alters cholesterol biosynthesis through tissue-dependent inhibition of emopamil binding protein and dehydrocholesterol reductase 24

LB Allen, TC Genaro-Mattos, A Anderson… - ACS chemical …, 2020 - ACS Publications
Amiodarone is prescribed for the treatment and prevention of irregular heartbeats. Although
effective in clinical practice, the long-term use of amiodarone has many unwanted side …

[PDF][PDF] Неалкогольная жировая болезнь печени: механизмы развития, клинические формы и медикаментозная коррекция

ИВ Маев, ДН Андреев - Consilium medicum. Гастроэнтерология, 2012 - omnidoctor.ru
ИВ Маев, ДН Андреев ГБОУ ВПО МГМСУ им. АИ Евдокимова Минздрава РФ ния,
длительное парентеральное питание, синдром избыточного бактериального …

Strategies for the early detection of drug-induced hepatic steatosis in preclinical drug safety evaluation studies

DE Amacher - Toxicology, 2011 - Elsevier
Hepatic steatosis is characterized by the accumulation of lipid droplets in the liver. Although
relatively benign, simple steatosis can eventually lead to the development of steatohepatitis …

Drug-induced steatohepatitis leading to cirrhosis: long-term toxicity of amiodarone use

K Raja, SN Thung, MI Fiel… - Seminars in Liver Disease, 2009 - thieme-connect.com
Nonalcoholic steatosis/steatohepatitis is the most common cause for abnormal liver
chemistries. Apart from metabolic syndrome, drugs may also lead to development of …

[HTML][HTML] Amiodarone-induced cirrhosis of liver: what predicts mortality?

N Hussain, A Bhattacharyya… - International Scholarly …, 2013 - hindawi.com
Introduction. Amiodarone has been used for more than 5 decades for the treatment of
various tachyarrhythmias and previously for the treatment of refractory angina. There are …